If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Viatris (VTRS) announced it has filed applications to the Ministry of Health, Labor and Welfare for approval of Effexor SR Capsules, a ...

SaveHealth assesses the relative benefits of Zoloft vs. Lexapro, comparing their usage, effectiveness, tolerability, ...

SSRI medications have come under scrutiny as of late, despite medical experts maintaining they're safe and effective.

New research reveals that serotonin plays a key role in how the brain predicts future rewards, shedding light on its puzzling activity in response to both pleasure and pain.

GLP-1 RAs and SGLT2 inhibitors significantly reduce cardiovascular events and heart failure risk in older adults with type 2 diabetes compared to DPP-4 inhibitors. The study utilized health ...

The presentation highlighted tolebrutinib’s potential as the first Bruton’s tyrosine kinase (BTK) inhibitor to receive regulatory approval for the treatment of progressive MS. During the Clinical ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the ...

A once-daily oral PCSK9 inhibitor reduced LDL in patients with hypercholesterolemia. Safety and tolerability profiles were favorable, according to investigators. CHICAGO — In a phase 2b study ...

Compared with placebo, SGLT2 inhibitors reduced heart failure hospitalizations among patients with history of myocardial infarction. Sodium-glucose co-transporter 2 (SGLT2) inhibitors may ...